跳至主要内容
临床试验/NCT03847558
NCT03847558Unknown不适用

Assessment of Sexual Maturation in β-Thalassemia Major Patients Receiving Iron Chelation Therapy in Assiut University Hospital

Assiut University0 个研究点目标入组 100 人开始时间: 2019年4月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
calculate body mass index (kg/m^2)

研究概览

简要总结

cross sectional study to asses sexual maturation in β-Thalassemia Major patients receiving Iron Chelation Therapy in assuit University Hospital and maintenance of 2ry sexual characters and reproduction

详细描述

Thalassemia refers to a group of inherited diseases characterized by decreased or absent synthesis of normal globin chains . The direct consequence is an imbalance of the alpha and beta globin chain synthesis that results in anemia from ineffective erythropoiesis and hemolysis.

The term thalassemia major refers to the severe form that is often associated with life-long transfusion dependent anemia.

Hypogonadism is the most frequently reported endocrine complication, affecting 70-80% of thalassemia major patients. Hypogonadism is likely to be caused by iron deposits in the gonads, pituitary gland or both.

Hypogonadotropic hypogonadism resulting from iron deposition in the pituitary gonadotrope is more commonly found than gonadal iron deposition in ovaries or testes occurs.

Iron deposition in the anterior pituitary gland can be demonstrated beginning in the first decade of life, but clinical manifestations are usually not evident until the onset of puberty. At the earlier stage, only a diminished gonadotropin reserve with intact gonadotropin pulse was observed .

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
10 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • β-thalassemic Patients aged 10 years and older
  • β-thalassemic patients receiving regular blood transfusions
  • All patients are on chelation therapy

排除标准

  • β-thalassemic patients with major system complications as cardiac ,renal or hepatic.
  • Patients not receiving chelation therapy
  • Patients with other hemolytic anemia

结局指标

主要结局

calculate body mass index (kg/m^2)

时间窗: 1 year

assesment of hieght in meters,weight in kilograms.

sexual maturation in patients receiving regular chelation will be compared to patients not receiving chelation helps us to improve quality of life for these patients and have normal sexual life

时间窗: 1 year

The present study will be carried out on previously diagnosed transfusion dependent thalassemia patients under chelation therapy in Assiut University children hospital. 1. patients will be selected and examined clinically to asses thier sexual maturation by measuring presence of secondary sexual characters. 2. hormonal assesment for patients including FSH,LH,Serum Testosterone.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ayman ekram

Principal Investigator

Assiut University

相似试验

Sexual Maturation in β-Thalassemia Major Patients in... | 临床试验